IRCT20120215009014N467招募中3 期
Effect of Sylimarin versus placebo on the reduction of liver complication of Teriflunomide in patients with multiple sclerosis: a double-blind randomized clinical trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 42
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 70 years（—）
- 性别
- All
入选标准
- •Age 18 to 70 years
- •Multiple sclerosis
排除标准
- •Pregnancy or breastfeeding
- •Alcohol consumption
- •Active viral hepatitis or chronic liver disease
研究者
相似试验
招募中
3 期
The effect of silymarin on serum liver enzyme level in patients with traumaIRCT20190911044744N1Shiraz University of Medical Sciences90
进行中（未招募）
1 期
A dose-finding clinical study investigating the effects of different doses of silymarin compared to placebo on elevated liver enzymes due to drug-induced liver enzyme elevation.EUCTR2020-004645-36-DEFraunhofer Gesellschaft for its Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP)156
招募中
不适用
Investigation the effect of herbal supplement on lead concentratiolead poisoning.Abnormal lead level in bloodR78.71IRCT20171122037584N1Hamedan University of Medical Sciences60
已完成
2 期
Impact of Silymarin Dosages to Decrease Drug-induced Elevated Liver Enzymes Compared to PlaceboDrug-induced Liver InjuryNCT05144217Prof. Dr. Frank Behrens19
已完成
2 期
The effect of salimarin in patients with multiple sclerosisMultiple sclerosisIRCT20150628022956N7Research Council of Hamedan University of Medical Sciences48